TP53 and lung cancer: The study found significantly decreased expression of P53 and the P53-related lncRNA PRAL in lung cancer lesions compared with that in adjacent normal tissues, whereas ectopic expression of PRAL in NSCLC cell lines remarkably inhibited the proliferation of tumor cells.